June 12, 2013
Bioniche Founder and CEO Addresses Shareholders

June 5, 2013
Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin™ Licensing Deals

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.

Please note that all media inquiries for Bioniche Life Sciences Inc. and its business divisions are addressed through our corporate headquarters in Belleville, Ontario, Canada. International inquiries will be directed to appropriate local contacts as necessary.

Jennifer Shea
Vice-President, Communications, Investor & Government Relations
P.O. Box 1570
Belleville, Ontario, Canada K8N 5J2

Tel: (613) 966-8058 ext. 1250 or (800) 265-5464
Fax: (613) 966-4177
Jennifer.Shea@Bioniche.com